ReviewMolecules (Basel, Switzerland)2026
New Insights into the Pharmacological Effects and Potential Health Benefits of Volatile Phenylpropenes.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phenylpropenes are a significant category of plant volatile compounds that play a crucial role in enhancing the flavor of a variety of herbs and spices. They are a subclass of phenylpropanoid compounds, being important constituents in several plant species like basil, clove, cinnamon, anise, sassafras, nutmeg, and fennel. The most common molecules from the phenylpropene group are represented by anethole, chavicol, cinnamaldehyde, estragole, eugenol, myristicin (methoxy-safrole), and safrole. Beyond their culinary and cosmetic applications, phenylpropenes have been found to have multiple pharmacological effects, including being antimicrobial, antitumoral, antioxidant, anti-inflammatory, antidiabetic, and hypolipemic. This review is focused on the presentation of the latest scientific data resulting mainly from preclinical in vivo and in vitro studies which investigated the pharmacological effects of phenylpropenes, highlighting also the potential health benefits of phenylpropenes in several infectious, inflammatory, cardiovascular, and metabolic diseases. Mechanistic aspects regarding their biological effects and additional safety data are also reviewed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.